Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis

被引:0
作者
Paschos, K. A. [1 ]
Bird, N. [1 ]
机构
[1] Univ Sheffield, Sch Med & Biomed Sci, Unit Surg Oncol, Royal Hallamshire Hosp, Sheffield S10 2TN, S Yorkshire, England
关键词
colorectal cancer; liver metastasis; liver metastasectomy; ablation; chemotherapy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Colorectal cancer is the second leading cause of cancer death in the developed world, due to fori-nation of distant metastases. The liver is a primary target organ of metastatic lesions, which substantially influence the morbidity of the disease. Prompt diagnosis of colorectal liver metastases leads to early treatment, which favours a better prognosis. Consequently, the diagnostic process has shifted from traditional clinical and biochemical procedures to technologically advanced imaging modalities, such as CT, MRI, FDG-PET and PET-CT. However, the only current curative therapeutic approach is the surgical resection of metastases, using the new methods of tissue excision and haemostasis. New therapeutic modalities like cryo- or radiofrequency ablation and portal vein embolisation as well as pharmaceutical innovations such as hepatic arterial infusion chemotherapy, isolated hepatic perfusion and contemporary chemotherapeutic regimens have emerged. While still under evaluation, they present promise for the future treatment of unresectable liver metastases.
引用
收藏
页码:132 / 138
页数:7
相关论文
共 62 条
[1]  
ABELOFF MAJ, 2004, CLIN ONCOLOGY LIVER, P1141
[2]  
ACKERMAN NB, 1974, SURGERY, V75, P589
[3]   Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases [J].
Adam, R .
ANNALS OF ONCOLOGY, 2003, 14 :13-16
[4]   Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors [J].
Adam, R ;
Laurent, A ;
Azoulay, D ;
Castaing, D ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 232 (06) :777-784
[5]   Liver resection for colorectal metastases - The third hepatectomy [J].
Adam, R ;
Pascal, G ;
Azoulay, D ;
Tanaka, K ;
Castaing, D ;
Bismuth, H .
ANNALS OF SURGERY, 2003, 238 (06) :871-883
[6]  
ALASFOOR A, 2007, COCHRANE DB SYST REV, V4
[7]   Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study [J].
Alberts, SR ;
Horvath, WL ;
Stcrnfeld, WC ;
Goldberg, RM ;
Mahoney, MR ;
Dakhil, SR ;
Levitt, R ;
Rowland, K ;
Nair, S ;
Sargent, DJ ;
Donohue, JH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9243-9249
[8]   Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver [J].
Azoulay, D ;
Castaing, D ;
Krissat, J ;
Smail, A ;
Hargreaves, GM ;
Lemoine, A ;
Emile, JF ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 232 (05) :665-672
[9]   Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer [J].
Bartlett, DL ;
Libutti, SK ;
Figg, WD ;
Fraker, DL ;
Alexander, HR .
SURGERY, 2001, 129 (02) :176-187
[10]  
Bipat S, 2007, NETH J MED, V65, P5